Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer

Basit Öğe Kaydı
dc.authorid0000-0002-4075-6692en_US
dc.contributor.authorKandemir, E. G.
dc.contributor.authorMayadağlı, A.
dc.contributor.authorYaylacı, M.
dc.contributor.authorÖztürk, A.
dc.date.accessioned2024-07-12T21:04:43Z
dc.date.available2024-07-12T21:04:43Z
dc.date.issued2005en_US
dc.departmentFakülteler, Tıp Fakültesien_US
dc.description.abstractWe investigated the prevalence of anaemia (haemoglobin concentration < 12 g/dl) in 336 women with early-stage breast cancer and its association with other known prognostic factors. The median follow-up period was 60.5 months (range 9-123 months). Seventy-nine women (23.5%) had a low pre-treatment haemoglobin concentration, but anaemia was not correlated with age, tumour size, nodal status, histological grade or hormone receptor status. Univariate analysis revealed that disease-free survival and overall survival were shorter in patients with anaemia at the time of diagnosis than in patients with normal haemoglobin concentrations. Anaemia remained a significant prognostic factor for disease-free survival and overall survival in the multivariate analysis (relative risk, 1.884 and 1.785, respectively). These results suggest that pre-treatment haemoglobin concentration is an independent prognostic factor in patients with early-stage breast cancer.en_US
dc.identifier.citationKandemir, E. G., Mayadagli, A., Turken, O., Yaylaci, M., & Ozturk, A. (2005). Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer. The Journal of international medical research, Sage Journals. 33(3), 319–328.en_US
dc.identifier.endpage328en_US
dc.identifier.issn0300-0605
dc.identifier.issn1473-2300
dc.identifier.issue3en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage319en_US
dc.identifier.urihttps://journals.sagepub.com/doi/abs/10.1177/147323000503300307
dc.identifier.urihttps://hdl.handle.net/20.500.12415/3823
dc.identifier.volume33en_US
dc.institutionauthorTürken, Orhan
dc.language.isoenen_US
dc.publisherSage Journalsen_US
dc.relation.ispartofJournal of International Medical Researchen_US
dc.relation.isversionof10.1177/147323000503300307en_US
dc.relation.publicationcategoryUluslararası Hakemli Dergide Makale - Kurum Öğretim Elemanıen_US
dc.rightsCC0 1.0 Universal*
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.snmzKY01938
dc.subjectBreast canceren_US
dc.subjectAnaemiaen_US
dc.subjectHaemoglobin concentrationen_US
dc.subjectPrognostic factorsen_US
dc.titlePre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast canceren_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

Tıp Fakültesi Koleksiyonu